Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)Tax Rate
Others
Ratios

NewGenIvf (NIVF) Income towards Parent Company: 2021-2024

Historic Income towards Parent Company for NewGenIvf (NIVF) over the last 4 years, with Dec 2024 value amounting to -$474,101.

  • NewGenIvf's Income towards Parent Company rose 55297.35% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.2 million, marking a year-over-year change of. This contributed to the annual value of -$474,101 for FY2024, which is 537.29% down from last year.
  • NewGenIvf's Income towards Parent Company amounted to -$474,101 in FY2024, which was down 537.29% from $108,418 recorded in FY2023.
  • Over the past 5 years, NewGenIvf's Income towards Parent Company peaked at $135,847 during FY2022, and registered a low of -$474,101 during FY2024.
  • Over the past 3 years, NewGenIvf's median Income towards Parent Company value was $108,418 (recorded in 2023), while the average stood at -$76,612.
  • As far as peak fluctuations go, NewGenIvf's Income towards Parent Company surged by 198.06% in 2022, and later tumbled by 537.29% in 2024.
  • Over the past 4 years, NewGenIvf's Income towards Parent Company (MRY) stood at -$138,532 in 2021, then surged by 198.06% to $135,847 in 2022, then fell by 20.19% to $108,418 in 2023, then crashed by 537.29% to -$474,101 in 2024.
  • Its Income towards Parent Company was -$474,101 in FY2024, compared to $108,418 in FY2023 and $135,847 in FY2022.